Point-of-care ultrasound guidance for long-acting cabotegravir-rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics.
Saved in:
| Title: | Point-of-care ultrasound guidance for long-acting cabotegravir-rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics. |
|---|---|
| Authors: | Padilla S; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia., Ledesma C; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia.; Infectious Diseases Unit, Hospital General Universitario de Elche., Fernández-González M; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia., Pérez-Calvo F; Infectious Diseases Unit, Hospital General Universitario de Elche., Bello-Perez M; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia., Losada-Echeberría M; Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández de Elche, Alicante, Spain., Barrajón-Catalán E; Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández de Elche, Alicante, Spain., García-Abellán J; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia., Mascarell P; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante., Botella Á; Infectious Diseases Unit, Hospital General Universitario de Elche., Masiá M; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia., Gutiérrez F; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia. |
| Source: | AIDS (London, England) [AIDS] 2026 May 01; Vol. 40 (5), pp. 622-626. Date of Electronic Publication: 2025 Dec 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41467702 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Point-of-care ultrasound guidance for long-acting cabotegravir-rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Padilla+S%22">Padilla S</searchLink>; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia.<br /><searchLink fieldCode="AU" term="%22Ledesma+C%22">Ledesma C</searchLink>; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia.; Infectious Diseases Unit, Hospital General Universitario de Elche.<br /><searchLink fieldCode="AU" term="%22Fernández-González+M%22">Fernández-González M</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia.<br /><searchLink fieldCode="AU" term="%22Pérez-Calvo+F%22">Pérez-Calvo F</searchLink>; Infectious Diseases Unit, Hospital General Universitario de Elche.<br /><searchLink fieldCode="AU" term="%22Bello-Perez+M%22">Bello-Perez M</searchLink>; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia.<br /><searchLink fieldCode="AU" term="%22Losada-Echeberría+M%22">Losada-Echeberría M</searchLink>; Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández de Elche, Alicante, Spain.<br /><searchLink fieldCode="AU" term="%22Barrajón-Catalán+E%22">Barrajón-Catalán E</searchLink>; Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universidad Miguel Hernández de Elche, Alicante, Spain.<br /><searchLink fieldCode="AU" term="%22García-Abellán+J%22">García-Abellán J</searchLink>; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia.<br /><searchLink fieldCode="AU" term="%22Mascarell+P%22">Mascarell P</searchLink>; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.<br /><searchLink fieldCode="AU" term="%22Botella+Á%22">Botella Á</searchLink>; Infectious Diseases Unit, Hospital General Universitario de Elche.<br /><searchLink fieldCode="AU" term="%22Masiá+M%22">Masiá M</searchLink>; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia.<br /><searchLink fieldCode="AU" term="%22Gutiérrez+F%22">Gutiérrez F</searchLink>; Infectious Diseases Unit and Department of Clinical Medicine, Hospital General Universitario and Universidad Miguel Hernández de Elche, Alicante.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid.; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228710219%22">AIDS (London, England)</searchLink> [AIDS] 2026 May 01; Vol. 40 (5), pp. 622-626. <i>Date of Electronic Publication: </i>2025 Dec 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8710219 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-5571 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202699370%22">02699370 </searchLink><i>NLM ISO Abbreviation: </i>AIDS <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41467702 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/QAD.0000000000004437 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 622 Titles: – TitleFull: Point-of-care ultrasound guidance for long-acting cabotegravir-rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Padilla S – PersonEntity: Name: NameFull: Ledesma C – PersonEntity: Name: NameFull: Fernández-González M – PersonEntity: Name: NameFull: Pérez-Calvo F – PersonEntity: Name: NameFull: Bello-Perez M – PersonEntity: Name: NameFull: Losada-Echeberría M – PersonEntity: Name: NameFull: Barrajón-Catalán E – PersonEntity: Name: NameFull: García-Abellán J – PersonEntity: Name: NameFull: Mascarell P – PersonEntity: Name: NameFull: Botella Á – PersonEntity: Name: NameFull: Masiá M – PersonEntity: Name: NameFull: Gutiérrez F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1473-5571 Numbering: – Type: volume Value: 40 – Type: issue Value: 5 Titles: – TitleFull: AIDS (London, England) Type: main |
| ResultId | 1 |
